Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study

A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from glioblastomas

(2022) Yae Won Park et al.   EUROPEAN RADIOLOGY

Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classification

(2022) Minjae Kim et al.   JOURNAL OF NEURO-ONCOLOGY

MGMT Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features

(2021) H.J. Choi et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas

(2021) C.J. Park et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter Study

(2021) Yae Won Park et al.   NEUROSURGERY

Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma

(2021) Sung Soo Ahn et al.   JOURNAL OF NEURO-ONCOLOGY

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

(2020) David N. Louis et al.   BRAIN PATHOLOGY

The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature

(2020) Victor M. Lu et al.   JOURNAL OF NEURO-ONCOLOGY

Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas

(2020) Yae Won Park et al.   EUROPEAN RADIOLOGY

Targeted copy number analysis outperforms histological grading in predicting patient survival for WHO grade II/III IDH-mutant astrocytomas

(2019) Patrick J Cimino et al.   NEURO-ONCOLOGY

Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study

(2019) Philipp Kickingereder et al.   LANCET ONCOLOGY

IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations

(2019) Rui Ryan Yang et al.   BRAIN PATHOLOGY

MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization

(2019) Sohil H. Patel et al.   RADIOLOGY

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

(2018) Mitsuaki Shirahata et al.   ACTA NEUROPATHOLOGICA

Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis

(2018) Chong Hyun Suh et al.   EUROPEAN RADIOLOGY

Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels

(2017) Jennifer Kerkhof et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas

(2017) Kosuke Aoki et al.   NEURO-ONCOLOGY

Adult IDH wild-type lower-grade gliomas should be further stratified

(2017) Abudumijit Aibaidula et al.   NEURO-ONCOLOGY

Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features

(2016) Philipp Kickingereder et al.   RADIOLOGY

CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing

(2016) Eric Talevich et al.   PLoS Computational Biology

IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO

(2015) David E. Reuss et al.   ACTA NEUROPATHOLOGICA

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

(2015) Adriana Olar et al.   ACTA NEUROPATHOLOGICA

CDKN2ALoss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II–III) Astrocytomas

(2015) Gerald F. Reis et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis

(2014) J. Cha et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Inactivation of the CDKN2A Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome

(2014) A. Alhejaily et al.   CLINICAL CANCER RESEARCH

Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging

(2013) Hee Ho Chu et al.   RADIOLOGY

MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set

(2013) David A. Gutman et al.   RADIOLOGY

P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3

(2012) Abdessamad Zerrouqi et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular diagnostics of gliomas: state of the art

(2010) Markus J. Riemenschneider et al.   ACTA NEUROPATHOLOGICA

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE